Published in J Invest Dermatol on September 01, 1992
A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest (1993) 2.19
Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J Exp Med (1998) 1.96
Hemidesmosome formation is initiated by the beta4 integrin subunit, requires complex formation of beta4 and HD1/plectin, and involves a direct interaction between beta4 and the bullous pemphigoid antigen 180. J Cell Biol (1998) 1.58
The role of complement in experimental bullous pemphigoid. J Clin Invest (1995) 1.55
A recombinant tail-less integrin beta 4 subunit disrupts hemidesmosomes, but does not suppress alpha 6 beta 4-mediated cell adhesion to laminins. J Cell Biol (1995) 1.46
The beta 4 subunit cytoplasmic domain mediates the interaction of alpha 6 beta 4 integrin with the cytoskeleton of hemidesmosomes. Mol Biol Cell (1993) 1.45
Role of binding of plectin to the integrin beta4 subunit in the assembly of hemidesmosomes. Mol Biol Cell (2003) 1.41
Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases. J Clin Invest (2005) 1.36
Myotactin, a novel hypodermal protein involved in muscle-cell adhesion in Caenorhabditis elegans. J Cell Biol (1999) 1.30
A critical role for neutrophil elastase in experimental bullous pemphigoid. J Clin Invest (2000) 1.30
92-kD gelatinase is produced by eosinophils at the site of blister formation in bullous pemphigoid and cleaves the extracellular domain of recombinant 180-kD bullous pemphigoid autoantigen. J Clin Invest (1994) 1.26
Synergy between a plasminogen cascade and MMP-9 in autoimmune disease. J Clin Invest (2005) 1.25
Serine phosphorylation of the integrin beta4 subunit is necessary for epidermal growth factor receptor induced hemidesmosome disruption. Mol Biol Cell (2007) 1.22
Keratinocytes from patients lacking collagen XVII display a migratory phenotype. Am J Pathol (2004) 1.20
Compound heterozygosity for a dominant glycine substitution and a recessive internal duplication mutation in the type XVII collagen gene results in junctional epidermolysis bullosa and abnormal dentition. Am J Pathol (1996) 1.19
180-kD bullous pemphigoid antigen (BP180) is deficient in generalized atrophic benign epidermolysis bullosa. J Clin Invest (1995) 1.16
The N terminus of the transmembrane protein BP180 interacts with the N-terminal domain of BP230, thereby mediating keratin cytoskeleton anchorage to the cell surface at the site of the hemidesmosome. Mol Biol Cell (2000) 1.14
The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases. Am J Pathol (2000) 1.10
Specificity of binding of the plectin actin-binding domain to beta4 integrin. Mol Biol Cell (2003) 1.09
The localization of bullous pemphigoid antigen 180 (BP180) in hemidesmosomes is mediated by its cytoplasmic domain and seems to be regulated by the beta4 integrin subunit. J Cell Biol (1997) 1.07
Identification and characterization of autoreactive T cell responses to bullous pemphigoid antigen 2 in patients and healthy controls. J Clin Invest (1998) 1.00
Subepidermal blistering induced by human autoantibodies to BP180 requires innate immune players in a humanized bullous pemphigoid mouse model. J Autoimmun (2008) 0.99
Three novel homozygous point mutations and a new polymorphism in the COL17A1 gene: relation to biological and clinical phenotypes of junctional epidermolysis bullosa. Am J Hum Genet (1997) 0.98
Cloning of the human type XVII collagen gene (COL17A1), and detection of novel mutations in generalized atrophic benign epidermolysis bullosa. Am J Hum Genet (1997) 0.93
Autoantibodies against adhesion molecules and structures in blistering skin diseases. J Exp Med (1995) 0.93
The majority of bullous pemphigoid and herpes gestationis serum samples react with the NC16a domain of the 180-kDa bullous pemphigoid antigen. Arch Dermatol Res (1996) 0.92
Collagen XVII: a shared antigen in neurodermatological interactions? Clin Dev Immunol (2013) 0.92
Anti-laminin gamma-1 pemphigoid. Proc Natl Acad Sci U S A (2009) 0.90
Role of different pathways of the complement cascade in experimental bullous pemphigoid. J Clin Invest (2006) 0.90
A novel ELISA reveals high frequencies of BP180-specific IgE production in bullous pemphigoid. J Immunol Methods (2009) 0.89
Collagen XVII (BP180) modulates keratinocyte expression of the proinflammatory chemokine, IL-8. Exp Dermatol (2012) 0.89
Molecular identification of collagen 17a1 as a major genetic modifier of laminin gamma 2 mutation-induced junctional epidermolysis bullosa in mice. PLoS Genet (2014) 0.89
Usefulness of Enzyme-linked Immunosorbent Assay Using Recombinant BP180 and BP230 for Serodiagnosis and Monitoring Disease Activity of Bullous Pemphigoid. Ann Dermatol (2012) 0.87
Differential roles for beta2 integrins in experimental autoimmune bullous pemphigoid. Blood (2005) 0.87
Dual targets for mouse mast cell protease-4 in mediating tissue damage in experimental bullous pemphigoid. J Biol Chem (2011) 0.86
The flavonoid luteolin inhibits Fcγ-dependent respiratory burst in granulocytes, but not skin blistering in a new model of pemphigoid in adult mice. PLoS One (2012) 0.85
Focal Contact and Hemidesmosomal Proteins in Keratinocyte Migration and Wound Repair. Adv Wound Care (New Rochelle) (2014) 0.83
Neutrophil elastase cleaves the murine hemidesmosomal protein BP180/type XVII collagen and generates degradation products that modulate experimental bullous pemphigoid. Matrix Biol (2011) 0.83
Type XVII collagen (BP180) can function as a cell-matrix adhesion molecule via binding to laminin 332. Matrix Biol (2010) 0.83
The NC16A domain of collagen XVII plays a role in triple helix assembly and stability. Biochem Biophys Res Commun (2006) 0.83
Elevated expression and release of tissue-type, but not urokinase-type, plasminogen activator after binding of autoantibodies to bullous pemphigoid antigen 180 in cultured human keratinocytes. Clin Exp Immunol (2004) 0.82
The C5a receptor on mast cells is critical for the autoimmune skin-blistering disease bullous pemphigoid. J Biol Chem (2011) 0.82
Experimental models for the autoimmune and inflammatory blistering disease, Bullous pemphigoid. Arch Dermatol Res (2007) 0.81
Development of an ELISA for sensitive and specific detection of IgA autoantibodies against BP180 in pemphigoid diseases. Orphanet J Rare Dis (2011) 0.80
Dynamic interactions of epidermal collagen XVII with the extracellular matrix: laminin 332 as a major binding partner. Am J Pathol (2011) 0.80
Absence of human herpesvirus 8 in pemphigus and bullous pemphigoid. Int J Clin Exp Pathol (2009) 0.79
Missing the target: characterization of bullous pemphigoid patients who are negative using the BP180 enzyme-linked immunosorbant assay. J Am Acad Dermatol (2012) 0.79
Passive transfer of collagen XVII-specific antibodies induces sustained blistering disease in adult mice. Orphanet J Rare Dis (2013) 0.77
IgG4 autoantibodies are inhibitory in the autoimmune disease bullous pemphigoid. J Autoimmun (2016) 0.77
14-3-3 sigma isoform interacts with the cytoplasmic domain of the transmembrane BP180 in keratinocytes. J Cell Physiol (2007) 0.76
Robust memory responses against influenza vaccination in pemphigus patients previously treated with rituximab. JCI Insight (2017) 0.75
Clinical and serological responses following plasmapheresis in bullous pemphigoid: two case reports and a review of the literature. Blood Transfus (2014) 0.75
The molecules in the corneal basement membrane zone affected by mustard exposure suggest potential therapies. Ann N Y Acad Sci (2016) 0.75
Identification of six polymorphisms as novel susceptibility loci for ischemic or hemorrhagic stroke by exome-wide association studies. Int J Mol Med (2017) 0.75
Functional characterization of an IgE-class monoclonal antibody specific for the bullous pemphigoid autoantigen, BP180. Hybridoma (Larchmt) (2012) 0.75
UVB irradiation reduces the expression of pemphigoid antigens in organ-cultured normal human skin. Arch Dermatol Res (1994) 0.75
Induction of pemphigus in neonatal mice by passive transfer of IgG from patients with the disease. N Engl J Med (1982) 3.09
The serpin alpha1-proteinase inhibitor is a critical substrate for gelatinase B/MMP-9 in vivo. Cell (2000) 2.49
Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting. J Immunol (1986) 2.30
Pemphigus: is there another half of the story? J Invest Dermatol (2001) 2.22
A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid, using antibodies generated against the hemidesmosomal antigen, BP180. J Clin Invest (1993) 2.19
Gelatinase B-deficient mice are resistant to experimental bullous pemphigoid. J Exp Med (1998) 1.96
The pathogenic effect of IgG4 autoantibodies in endemic pemphigus foliaceus (fogo selvagem). N Engl J Med (1989) 1.88
Complete bundle branch block as an independent predictor of all-cause mortality: report of 7,073 patients referred for nuclear exercise testing. Am J Med (2001) 1.84
Epidemic Venezuelan equine encephalitis in La Guajira, Colombia, 1995. J Infect Dis (1997) 1.75
Isolation of a Bacterial Culture That Degrades Methyl t-Butyl Ether. Appl Environ Microbiol (1994) 1.70
A pool of bullous pemphigoid antigen(s) is intracellular and associated with the basal cell cytoskeleton-hemidesmosome complex. J Invest Dermatol (1985) 1.67
The prevalence of antibodies against desmoglein 1 in endemic pemphigus foliaceus in Brazil. Cooperative Group on Fogo Selvagem Research. N Engl J Med (2000) 1.58
Mucosal and mucocutaneous (generalized) pemphigus vulgaris show distinct autoantibody profiles. J Invest Dermatol (1997) 1.56
The role of complement in experimental bullous pemphigoid. J Clin Invest (1995) 1.55
A major role for neutrophils in experimental bullous pemphigoid. J Clin Invest (1997) 1.53
Behçet's disease. Int J Dermatol (1984) 1.45
Bullous pemphigoid and herpes gestationis autoantibodies recognize a common non-collagenous site on the BP180 ectodomain. J Immunol (1993) 1.44
D-penicillamine-induced pemphigus foliaceus with autoantibodies to desmoglein-1 in a patient with mixed connective tissue disease. J Am Acad Dermatol (1997) 1.43
The role of subclass switching in the pathogenesis of endemic pemphigus foliaceus. J Invest Dermatol (2003) 1.43
Mast cells play a key role in neutrophil recruitment in experimental bullous pemphigoid. J Clin Invest (2001) 1.42
Pemphigoid and pemphigus antigens in cultured epidermal cells. Br J Dermatol (1978) 1.32
The anti-desmoglein 1 autoantibodies in pemphigus vulgaris sera are pathogenic. J Invest Dermatol (1999) 1.30
A critical role for neutrophil elastase in experimental bullous pemphigoid. J Clin Invest (2000) 1.30
Tight clustering of extracellular BP180 epitopes recognized by bullous pemphigoid autoantibodies. J Invest Dermatol (1997) 1.26
An epitope in the third hypervariable region of the DRB1 gene is involved in the susceptibility to endemic pemphigus foliaceus (fogo selvagem) in three different Brazilian populations. Tissue Antigens (1997) 1.24
Intravenous rt-PA for acute stroke: comparing its effectiveness in younger and older patients. J Neurol Neurosurg Psychiatry (2005) 1.22
Identification of two collagen domains within the bullous pemphigoid autoantigen, BP180. J Clin Invest (1991) 1.21
Isolation of pemphigus antigen from human saliva. J Immunol (1980) 1.20
Sequence analysis of 515 kinase genes in chronic lymphocytic leukemia. Leukemia (2011) 1.18
Monovalent Fab' immunoglobulin fragments from endemic pemphigus foliaceus autoantibodies reproduce the human disease in neonatal Balb/c mice. J Clin Invest (1990) 1.16
Herpes gestationis autoantibodies recognize a 180-kD human epidermal antigen. J Clin Invest (1988) 1.14
Development and characterization of desmoglein-3 specific T cells from patients with pemphigus vulgaris. J Clin Invest (1997) 1.13
Desmoglein-1-specific T lymphocytes from patients with endemic pemphigus foliaceus (fogo selvagem). J Clin Invest (2000) 1.12
Mechanisms of acantholysis in pemphigus vulgaris: role of IgG valence. Clin Immunol Immunopathol (1997) 1.05
Cicatricial pemphigoid autoantibodies react with multiple sites on the BP180 extracellular domain. J Invest Dermatol (1996) 1.04
Responsiveness of human T lymphocytes to bacterial superantigens presented by cultured rheumatoid arthritis synoviocytes. Arthritis Rheum (1996) 1.02
The use of human pemphigoid autoantibodies to study the fate of epidermal basal cell hemidesmosomes after trypsin dissociation. J Invest Dermatol (1985) 1.01
In vivo blockade of pemphigus vulgaris acantholysis by inhibition of intracellular signal transduction cascades. Br J Dermatol (2004) 1.00
A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid. J Invest Dermatol (1997) 1.00
A recombinant form of the human BP180 ectodomain forms a collagen-like homotrimeric complex. Biochemistry (1997) 0.99
Bullous pemphigoid and cicatricial pemphigoid autoantibodies react with ultrastructurally separable epitopes on the BP180 ectodomain: evidence that BP180 spans the lamina lucida. J Invest Dermatol (1997) 0.99
Genomic organization of collagenous domains and chromosomal assignment of human 180-kDa bullous pemphigoid antigen-2, a novel collagen of stratified squamous epithelium. J Biol Chem (1991) 0.98
Definition of bullous pemphigoid antibody binding to intracellular and extracellular antigen associated with hemidesmosomes. J Invest Dermatol (1989) 0.98
Bullous pemphigoid antigen: isolation from normal human skin. J Immunol (1977) 0.98
Pemphigus foliaceus and pemphigus vulgaris autoantibodies react with the extracellular domain of desmoglein-1. J Invest Dermatol (1995) 0.97
An active focus of high prevalence of fogo selvagem on an Amerindian reservation in Brazil. Cooperative Group on Fogo Selvagem Research. J Invest Dermatol (1996) 0.97
Reliability assessment in advanced nanocomposite materials for orthopaedic applications. J Mech Behav Biomed Mater (2010) 0.97
HLA antigens and risk for development of pemphigus foliaceus (fogo selvagem) in endemic areas of Brazil. Immunogenetics (1991) 0.95
Demonstration of pemphigus antibodies on the cell surface of murine epidermal cell monolayers and their internalization. J Invest Dermatol (1984) 0.94
The hemidesmosomal plaque. I. Characterization of a major constituent protein as a differentiation marker for certain forms of epithelia. Differentiation (1990) 0.94
Bullous pemphigoid antigen. II. Isolation from the urine of a patient. J Immunol (1979) 0.94
Molecular mapping of a pathogenically relevant BP180 epitope associated with experimentally induced murine bullous pemphigoid. J Immunol (1995) 0.93
Experimentally induced pemphigus vulgaris in neonatal BALB/c mice: a time-course study of clinical, immunologic, ultrastructural, and cytochemical changes. J Invest Dermatol (1985) 0.93
Pathogenic effects of bullous pemphigoid autoantibodies on rabbit corneal epithelium. J Clin Invest (1981) 0.92
Posterior cingulate metabolic changes occur in Parkinson's disease patients without dementia. Neurosci Lett (2004) 0.91
Beta2-microglobulin-deficient mice are resistant to bullous pemphigoid. J Exp Med (1997) 0.91
Serologic abnormalities in patients with endemic pemphigus foliaceus (Fogo selvagem), their relatives, and normal donors from endemic and non-endemic areas of Brazil. J Invest Dermatol (1988) 0.91
Endemic pemphigus foliaceus (fogo selvagem)--1998. The Cooperative Group on Fogo Selvagem Research. Clin Dermatol (1999) 0.91
Phylogenetic studies with pemphigus and pemphigoid antibodies. Acta Derm Venereol (1978) 0.90
Pemphigus and pemphigoid antigens are expressed in human amnion epithelium. J Invest Dermatol (1984) 0.90
Herpes gestationis. Clin Dermatol (2001) 0.89
Development of an ELISA to detect anti-BP180 autoantibodies in bullous pemphigoid and herpes gestationis. J Invest Dermatol (1994) 0.89
Defining the role of complement in experimental pemphigus vulgaris in mice. J Immunol (1986) 0.89
A sensitive and specific assay to detect Ro(SS-A) and La(SS-B) antibodies. J Invest Dermatol (1986) 0.89
Specificity and inhibition of the epidermal cell detachment induced by pemphigus IgG in vitro. J Invest Dermatol (1983) 0.89
Pathogenesis of scleroderma. Current concepts. Int J Dermatol (1984) 0.89
Separation of epidermis from dermis with sodium thiocyanate. J Invest Dermatol (1977) 0.88
Characterization of a novel keratinocyte ubiquitin carrier protein. J Biol Chem (1996) 0.88
Animal models for bullous pemphigoid. Clin Dermatol (1987) 0.86
Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801. J Invest Dermatol (1999) 0.86
Linear immunofluorescence staining of the cutaneous basement membrane zone produced by pemphigoid antibodies: the result of hemidesmosome staining. J Am Acad Dermatol (1987) 0.86
UVB-induced acantholysis in endemic Pemphigus foliaceus (Fogo selvagem) and Pemphigus vulgaris. J Am Acad Dermatol (2000) 0.85
An autoantibody in pemphigus serum, specific for the 59 kD keratin, selectively binds the surface of keratinocytes: evidence for an extracellular keratin domain. J Invest Dermatol (1987) 0.85
The pattern of expression of CD147/neurothelin during human T-cell ontogeny as defined by the monoclonal antibody 8D6. Tissue Antigens (1997) 0.85
Endemic pemphigus foliaceus in western Parana, Brazil (1976-1988). Cooperative Group for Fogo Selvagem Research. Br J Dermatol (1990) 0.84
Pregnant women with endemic pemphigus foliaceus (Fogo Selvagem) give birth to disease-free babies. J Invest Dermatol (1992) 0.84
The human 4F2 antigen: evidence for cryptic and noncryptic epitopes and for a role of 4F2 in human T lymphocyte activation. Cell Immunol (1994) 0.84
Endemic pemphigus foliaceus. Fogo selvagem. Dermatol Clin (1993) 0.84
Pemphigus foliaceus antigen: characterization of an immunoreactive tryptic fragment from BALB/c mouse epidermis recognized by all patients' sera and major autoantibody subclasses. Clin Immunol Immunopathol (1990) 0.84
Suppressor cell function is preserved in pemphigus and pemphigoid. J Invest Dermatol (1982) 0.84
Pemphigus foliaceus sera recognize an N-terminal fragment of bovine desmoglein 1. J Invest Dermatol (1994) 0.84
Calcium enhances the sensitivity of immunofluorescence for pemphigus antibodies. J Invest Dermatol (1987) 0.83
Subclass reactivity of pemphigus foliaceus autoantibodies with recombinant human desmoglein. J Invest Dermatol (1993) 0.83
In vitro alterations of epidermal cell adhesion induced by temperature, substrate, and cations. J Invest Dermatol (1981) 0.83
Prospects for autoimmune disease: Research advances in pemphigus. JAMA (2001) 0.83
Persistent pulmonary hypertension of the newborn presenting as the primary manifestation of intracranial arteriovenous malformation of the Vein of Galen. Am J Perinatol (2000) 0.82
Acute extradural haematoma following trivial trauma in a case of osteogenesis imperfecta. Neurochirurgia (Stuttg) (1985) 0.82
Autoantibodies in lichen planus pemphigoides react with a novel epitope within the C-terminal NC16A domain of BP180. J Invest Dermatol (1999) 0.82
Identification and characterization of epitopes recognized by T lymphocytes and autoantibodies from patients with herpes gestationis. J Immunol (1999) 0.82
E-cadherin autoantibody profile in patients with pemphigus vulgaris. Br J Dermatol (2013) 0.82
Characterization of pemphigus foliaceus antigen from human epidermis. J Invest Dermatol (1991) 0.82
Dexamethasone inhibits plasminogen activator activity in experimental pemphigus in vivo but does not block acantholysis. J Immunol (1986) 0.82
Ultrastructural studies of acantholysis induced in vivo by passive transfer of IgG from endemic pemphigus foliaceus (Fogo Selvagem). J Invest Dermatol (1989) 0.82
Nanostructured ceramic oxides with a slow crack growth resistance close to covalent materials. Nano Lett (2005) 0.82
Molecular mapping of the major epitopes of BP180 recognized by herpes gestationis autoantibodies. Clin Immunol (1999) 0.81